ECOL is up +10.29% in the last 5 days.
As of 09:56 ECOL is at 43.90 -0.26 -0.59%
US Ecology Inc (ECOL)
Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...
Continue Reading
A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...
Continue Reading
Solvang Strikers Prevail with New Deal Staring down the barrel of a five-week standoff, the hard-nosed workers of Solvang just proved exactly what grit can get you. The City of Solvang and the steadfast members of Teamsters Local 986 wrapped up their punchy back-and-forth by clinching a contract that ups the ante on wages and job respect. For a bunch who stuck it out on...
Continue Reading
Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...
Continue Reading
CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...
Continue Reading
Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...
Continue Reading
Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...
Continue Reading
Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...
Continue Reading
Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
Cartesian Therapeutics Enhances Workforce with Inducement Grants In an exciting development, Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a prominent clinical-stage biotechnology firm, has made significant strides in expanding its workforce by announcing the granting of inducement awards to five new employees. This move underscores the company's commitment to attracting...
Continue Reading
Archer Health Under Investigation for Patient Data Breach Archer Health, Inc., a provider of in-home healthcare services, is facing serious scrutiny after a significant data breach involving unauthorized access to sensitive patient records. The investigations are being led by Schubert Jonckheer & Kolbe LLP, which aims to provide clarity and assistance to those affected....
Continue Reading
ATEN's Award-Winning Networked AV Series Excellence ATEN International, a distinguished provider of AV/IT connectivity and management solutions, proudly announces its Networked AV Series has been awarded the esteemed Good Design Award for 2024. This recognition highlights the system's user-friendliness and its ability to deliver high-quality audio-visual (AV) transmission...
Continue Reading
Paul Vallis Appointed as CEO of Lubrication Engineers Lubrication Engineers (LE), a prominent player in high-performance industrial lubricants and asset reliability solutions, recently announced the appointment of Paul Vallis as their new Chief Executive Officer. This decision marks a transformative moment for LE, which has seen remarkable growth and expansion, including...
Continue Reading
Two Seas Capital Responds to Special Meeting Results Two Seas Capital LP, a notable alternative investment management firm, has expressed gratitude towards Core Scientific shareholders following the recent special meeting regarding the proposed sale to CoreWeave. With a commitment to transparency and effective communication, Two Seas reinforces its optimism about Core...
Continue Reading